Host-defense peptides in skin secretions of African clawed frogs (Xenopodinae, Pipidae)

General and Comparative Endocrinology

Volumn 176, Issue 3, 2012, Pages 513-518

  Michael Conlon, J ^a   Mechkarska, Milena ^a   King, Jay D ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Rare Species Conservatory Foundation   (United States)

Author keywords

Antimicrobial peptide; Caerulein precursor fragment; Magainin; PGLa; Xenopodinae; Xenopsin precursor fragment

Indexed keywords

CAERULEIN PRECURSOR FRAGMENT; CERULETIDE; GLYCYLLEUCINEAMIDE; GLYCYLLEUCYLGLYCYLSERYLVALYLLEUCYLGLYCYLASPARAGINYLALANYLLEUCYLARGINYLISOLEUCYLGLYCYLALANYLLYSYLLEUCYLLEUCINEAMIDE; GLYCYLLEUCYLGLYCYLSERYLVALYLLEUCYLGLYCYLLYSYLALANYLLEUCYLLYSYLISOLEUCYLGLYCYLALANYLASPARAGINYLLEUCYLLEUCINEAMIDE; GLYCYLMETHIONYLALANYLSERYLLYSYLALANYLGLYCYLSERYLISOLEUCYLVALYLGLYCYLLYSYLISOLEUCYLALANYLLYSYLISOLEUCYLALANYLLEUCYLGLYCYLALANYLLEUCINEAMIDE; GLYCYLMETHIONYLALANYLSERYLLYSYLALANYLGLYCYLSERYLVALYLLEUCYLGLYCYLLYSYLVALYLALANYLLYSYLVALYLALANYLLEUCYLLYSYLALANYLALANYLLEUCINEAMIDE; GLYCYLMETHIONYLALANYLSERYLLYSYLALANYLGLYCYLTHREONYLISOLEUCYLALANYLGLYCYLLYSYLISOLEUCYLALANYLLYSYLTHREONYLALANYLISOLEUCYLLYSYLLEUCYLALANYLLEUCINEAMIDE; GLYCYLMETHIONYLALANYLSERYLTHREONYLALANYLGLYCYLSERYLVALYLLEUCYLGLYCYLLYSYLLEUCYLALANYLLYSYLALANYLVALYLALANYLISOLEUCYLGLYCYLALANYLLEUCINEAMIDE; GLYCYLPHENYLALANYLLEUCYLGLYCYLPROLYLLEUCYLLEUCYLLYSYLLEUCYLGLYCYLLEUCYLLYSYLGLYCYLVALYLALANYLLYSYLVALYLLEUCYLPROLYLHISTIDYLLEUCYLISOLEUCYLPROLYLSERYLARGINYLGLUTAMINYLGLUTAMINE; GLYCYLPHENYLALANYLLEUCYLGLYCYLSERYLLEUCYLLEUCYLLYSYLTHREONYLGLYCYLLEUCYLLYSYLVALYLGLYCYLSERYLASPARAGINYLLEUCYLLEUCINEAMIDE; MAGAININ; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; XENOPSIN; XENOPSIN PRECURSOR FRAGMENT;

AFRICAN CLAWED FROG; ALLOPOLYPLOIDY; ARTICLE; BACTERICIDAL ACTIVITY; DIPLOIDY; ESCHERICHIA COLI; FROG; GENE PRODUCT; GENE SILENCING; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OCTOPLOIDY; PARALOGY; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SILURANA PARATROPICALIS; SILURANA TROPICALIS; SKIN SECRETION; SPECIES COMPARISON; STAPHYLOCOCCUS AUREUS; TETRAPLOIDY; XENOPUS; XENOPUS AMIETI; XENOPUS ANDREI; XENOPUS BOREALIS; XENOPUS CLIVII; XENOPUS LAEVIS; XENOPUS MUELLERI; XENOPUS PETERSII;

EID: 84859916531     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2011.10.010     Document Type: Article

References (49)

1. Ali M.F., Soto A., Knoop F.C., Conlon J.M. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim. Biophys. Acta 2001, 1500:81-89.
2. Almeida P.F., Pokorny A. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 2009, 48:8083-8093.
3. Conlon J.M. The contribution of skin antimicrobial peptides to the system of innate immunity in anurans. Cell Tissue Res. 2010, 343:201-212.
4. Conlon J.M., Al-Ghaferi N., Abraham B., Leprince J. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 2007, 42:349-357.
5. Conlon J.M., Al-Ghaferi N., Ahmed E., Meetani M.A., Leprince J., Nielsen P.F. Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti. Peptides 2010, 31:989-994.
6. Conlon J.M., Kolodziejek J., Nowotny N. Antimicrobial peptides from the skins of North American frogs. Biochim. Biophys. Acta 2009, 1788:1556-1563.
7. Conlon J.M., Mechkarska M., Ahmed E., Leprince J., Vaudry H., King J.D., Takada K. Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2011, 153:350-354.
8. Daszak P., Berger L., Cunningham A.A., Hyatt A.D., Green D.E., Speare R. Emerging infectious diseases and amphibian population declines. Emerg. Infect. Dis. 1999, 5:735-748.
9. de Queiroz K. The general lineage concept of species, species criteria, and the process of speciation. Endless Forms: Species and Speciation 1998, 57-75. Oxford Press, New York. D. Howard, S. Berlocher (Eds.).
10. de Sá R.O., Hillis D.M. Phylogenetic relationships of the pipid frogs Xenopus and Silurana: an integration of ribosomal DNA and morphology. Mol. Biol. Evol. 1990, 7:365-376.
11. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
12. Evans B.J. Ancestry influences the fate of duplicated genes millions of years after polyploidization of clawed frogs (Xenopus). Genetics 2007, 176:119-130.
13. Evans B.J. Genome evolution and speciation genetics of clawed frogs (Xenopus and Silurana). Front. Biosci. 2008, 13:4687-4706.
14. Evans B.J., Kelley D.B., Melnick D.J., Cannatella D.C. Evolution of RAG-1 in polyploid clawed frogs. Mol. Biol. Evol. 2005, 22:1193-1207.
15. Evans B.J., Kelley D.B., Tinsley R.C., Melnick D.J., Cannatella D.C. A mitochondrial DNA phylogeny of African clawed frogs: phylogeography and implications for polyploid evolution. Mol. Phylogenet. Evol. 2004, 33:197-213.
16. Falagas M.E., Kastoris A.C., Vouloumanou E.K., Dimopoulos G. Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:719-730.
17. Fisher M.A., Borgnakke W.S., Taylor G.W. Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2010, 19:519-526.
18. Fisher M.C., Garner T.W., Walker S.F. Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time, and host. Annu. Rev. Microbiol. 2009, 63:291-310.
19. D.R. Frost, Amphibian species of the world: an online reference, Version 5.5, American Museum of Natural History, New York, USA, 2011, Electronic database. Available from: http://research.amnh.org/herpetology/amphibia/index.php.
20. Ge Y., MacDonald D., Henry M.M., Hait H.I., Nelson K.A., Lipsky B.A., Zasloff M.A., Holroyd K.J. In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn. Microbiol. Infect. Dis. 1999, 35:45-53.
21. Giamarellou H., Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options ?. Drugs 2009, 69:1879-1901.
22. Gibson B.W., Poulter L., Williams D.H., Maggio J.E. Novel peptide fragments originating from PGLa and the caerulein and xenopsin precursors from Xenopus laevis. J. Biol. Chem. 1986, 261:5341-5349.
23. Giovannini M.G., Poulter L., Gibson B.W., Williams D.H. Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem. J. 1987, 243:113-120.
24. Hunt L.T., Barker W.C. Relationship of promagainin to three other prohormones from the skin of Xenopus laevis: a different perspective. FEBS Lett. 1988, 233:282-288.
25. James S., Gibbs B.F., Toney K., Bennett H.P. Purification of antimicrobial peptides from an extract of the skin of Xenopus laevis using heparin-affinity HPLC: characterization by ion-spray mass spectrometry. Anal. Biochem. 1994, 217:84-90.
26. Kobel H.R. Allopolyploid speciation. The Biology of Xenopus 1996, 391-401. Clarendon Press, Oxford. R.C. Tinsley, H.R. Kobel (Eds.).
27. Kobel H.R., Du Pasquier L. Genetics of Xenopus laevis. Methods Cell Biol. 1991, 36:9-34.
28. Kobel H.R., Loumont C., Tinsley R.C. The extant species. The Biology of Xenopus 1996, 9-33. Clarendon Press, Oxford. R.C. Tinsley, H.R. Kobel (Eds.).
29. Lynch M., Katju V. The altered evolutionary trajectories of gene duplicates. Trends Genet. 2004, 20:544-549.
30. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 2008, 46:1254-1263.
31. J. Measey, R. Tinsley, L. Minter, M.-O. Rödel, Xenopus muelleri. in: IUCN Red List of Threatened Species. Version 2011.1. Electronic database. Available from: http://www.iucnredlist.org.
32. Mechkarska M., Ahmed E., Coquet L., Leprince J., Jouenne T., Vaudry H., King J.D., Conlon J.M. Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae). Comp. Biochem. Physiol. C 2010, 152:467-472.
33. Mechkarska M., Ahmed E., Coquet L., Leprince J., Jouenne T., Vaudry H., King J.D., Takada K., Conlon J.M. Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions. Comp. Biochem. Physiol. D Genomics Proteomics 2011, 6:206-212.
34. Mechkarska M., Ahmed E., Coquet L., Leprince J., Jouenne T., Vaudry H., King J.D., Conlon J.M. Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Peptides 2011, 32:1502-1528.
35. Parker J.M., Mikaelian I., Han N., Diggs H.E. Clinical diagnosis and treatment of epidermal chytridiomycosis in African clawed frogs. (Xenopus tropicalis). Comp. Med. 2002, 52:265-268.
36. Powers J.P., Hancock R.E. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24:1681-1691.
37. Rollins-Smith L.A., Conlon J.M. Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations. Dev. Comp. Immunol. 2005, 29:589-598.
38. Rollins-Smith L.A., Doersam J.K., Longcore J.E., Taylor S.K., Shamblin J.C., Carey C., Zasloff M.A. Antimicrobial peptide defenses against pathogens associated with global amphibian declines. Dev. Comp. Immunol. 2002, 26:63-72.
39. Ryan R.P., Monchy S., Cardinale M., Taghavi S., Crossman L., Avison M.B., Berg G., van der Lelie D., Dow J.M. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 2009, 7:514-525.
40. Soravia E., Martini G., Zasloff M. Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett. 1988, 228:337-340.
41. Stice M.J., Briggs C.J. Immunization is ineffective at preventing infection and mortality due to the amphibian chytrid fungus Batrachochytrium dendrobatidis. J. Wildlife Dis. 2010, 46:70-77.
42. Tennessen J.A., Blouin M.S. Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation. J. Mol. Evol. 2007, 65:605-615.
43. Tennessen J.A., Woodhams D.C., Chaurand P., Reinert L.K., Billheimer D., Shyr Y., Caprioli R.M., Blouin M.S., Rollins-Smith L.A. Variations in the expressed antimicrobial peptide repertoire of northern leopard frog (Rana pipiens) populations suggest intraspecies differences in resistance to pathogens. Dev. Comp. Immunol. 2009, 33:1247-1257.
44. Tymowska J. Polyploidy and cytogenetic variation in frogs of the genus Xenopus. Amphibian Cytogenetics and Evolution 1991, 259-297. Academic Press, San Diego. D.M. Green, S.K. Sessions (Eds.).
45. Tymowska J., Fischberg M. A comparison of the karyotype, constitutive heterochromatin, and nucleolar organizer regions of the new tetraploid species Xenopus epitropicalis Fischberg and Picard with those of Xenopus tropicalis Gray (Anura, Pipidae). Cytogenet. Cell Genet. 1982, 34:49-157.
46. Voyles J., Young S., Berger L., Campbell C., Voyles W.F., Dinudom A., Cook D., Webb R., Alford R.A., Skerratt L.F., Speare R. Pathogenesis of chytridiomycosis. A cause of catastrophic amphibian declines. Science 2009, 326:582-585.
47. Weldon C., du Preez L.H., Hyatt A.D., Muller R., Spears R. Origin of the amphibian chytrid fungus. Emerg. Infect. Dis. 2004, 10:2100-2105.
48. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 1987, 84:5449-5453.
49. Zhang L., Falla T.J. Potential therapeutic application of host defense peptides. Methods Mol. Biol. 2010, 618:303-327.